Search Results

Association between GDF15, poverty and mortality in urban middle-aged African American and white adults.

• Authors : Freeman DW; Laboratory of Epidemiology and Population Science, National Institute on Aging Intramural Research Program (NIA IRP), National Institutes of Health (NIH), Baltimore, Maryland, United States of America.; Noren Hooten N

Subjects: Mortality* ; Poverty* ; Urban Health*

• Source: PloS one [PLoS One] 2020 Aug 07; Vol. 15 (8), pp. e0237059. Date of Electronic Publication: 2020 Aug 07 (Print Publication: 2020).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

Record details

Circulating Levels of Biomarkers of Cerebral Injury in Patients with Atrial Fibrillation.

• Authors : Galenko O; Intermountain Medical Center Heart Institute, Intermountain Medical Center, Salt Lake City, Utah.; Jacobs V

Subjects: Registries*; Atrial Fibrillation/Atrial Fibrillation/Atrial Fibrillation/*complications ; Brain Ischemia/Brain Ischemia/Brain Ischemia/*blood

• Source: The American journal of cardiology [Am J Cardiol] 2019 Dec 01; Vol. 124 (11), pp. 1697-1700. Date of Electronic Publication: 2019 Sep 06.Publisher: Excerpta Medica Country of Publication: United States NLM ID: 0207277 Publication Model: Print-Electronic Cited

Record details

Association of Multiple Biomarkers With Risk of All-Cause and Cause-Specific Mortality After Acute Coronary Syndromes: A Secondary Analysis of the PLATO Biomarker Study.

• Authors : Lindholm D; Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden.; Uppsala Clinical Research Center, Uppsala, Sweden.

Subjects: Acute Coronary Syndrome/Acute Coronary Syndrome/Acute Coronary Syndrome/*blood ; C-Reactive Protein/C-Reactive Protein/C-Reactive Protein/*metabolism ; Growth Differentiation Factor 15/Growth Differentiation Factor 15/Growth Differentiation Factor 15/*blood

• Source: JAMA cardiology [JAMA Cardiol] 2018 Dec 01; Vol. 3 (12), pp. 1160-1166.Publisher: American Medical Association Country of Publication: United States NLM ID: 101676033 Publication Model: Print

Record details

A prospective study of macrophage inhibitory cytokine-1 (MIC-1/GDF15) and risk of colorectal cancer.

• Authors : Mehta RS; Affiliations of authors: Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA (RSM, ATC); Gastrointestinal Research Group, Institute of Medical Sciences, Aberdeen University, Aberdeen, United Kingdom (NB)

Subjects: Colorectal Neoplasms/Colorectal Neoplasms/Colorectal Neoplasms/*metabolism ; Cyclooxygenase 2/Cyclooxygenase 2/Cyclooxygenase 2/*metabolism ; Growth Differentiation Factor 15/Growth Differentiation Factor 15/Growth Differentiation Factor 15/*metabolism

• Source: Journal of the National Cancer Institute [J Natl Cancer Inst] 2014 Apr; Vol. 106 (4), pp. dju016. Date of Electronic Publication: 2014 Feb 24.Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print-Electronic

Record details

Macrophage inhibitory cytokine-1 (MIC-1/GDF15) and mortality in end-stage renal disease.

• Authors : Breit SN; St Vincent’s Centre for Applied Medical Research, St Vincent’s Hospital, University of New South Wales, Sydney, Australia.; Carrero JJ

Subjects: Growth Differentiation Factor 15/Growth Differentiation Factor 15/Growth Differentiation Factor 15/*metabolism ; Kidney Failure, Chronic/Kidney Failure, Chronic/Kidney Failure, Chronic/*metabolism ; Kidney Failure, Chronic/Kidney Failure, Chronic/Kidney Failure, Chronic/*mortality

• Source: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association [Nephrol Dial Transplant] 2012 Jan; Vol. 27 Publisher: Oxford University Press Country of Publication: England NLM ID: 8706402 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Growth differentiation factor-15 and risk of recurrent events in patients stabilized after acute coronary syndrome: observations from PROVE IT-TIMI 22.

• Authors : Bonaca MP; TIMI Study Group, Brigham and Women's Hospital, Boston, MA 02115, USA. ; Morrow DA

Subjects: Acute Coronary Syndrome/Acute Coronary Syndrome/Acute Coronary Syndrome/*therapy ; Growth Differentiation Factor 15/Growth Differentiation Factor 15/Growth Differentiation Factor 15/*blood ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/Hydroxymethylglutaryl-CoA Reductase Inhibitors/Hydroxymethylglutaryl-CoA Reductase Inhibitors/*therapeutic use

• Source: Arteriosclerosis, thrombosis, and vascular biology [Arterioscler Thromb Vasc Biol] 2011 Jan; Vol. 31 (1), pp. 203-10. Date of Electronic Publication: 2010 Oct 21.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9505803 Publication Model:

Record details

Brief Report: Whole‐Exome Sequencing to Identify Rare Variants and Gene Networks That Increase Susceptibility to Scleroderma in African Americans.

• Authors : Gourh, Pravitt; Remmers, Elaine F.; Boyden, Steven E.

Subjects: SYSTEMIC scleroderma; ACADEMIC medical centers; BLACK peopleUNITED States

• Source: Arthritis & Rheumatology; Oct2018, Vol. 70 Issue 10, p1654-1660, 7p

Record details

Dissection of genomic correlation matrices of US Holsteins using multivariate factor analysis.

• Authors : Macciotta, N.P.P.; Dimauro, C.; Null, D.J.

Subjects: GENOMES; MATRICES (Mathematics); HOLSTEIN-Friesian cattleUNITED States

• Source: Journal of Animal Breeding & Genetics; Feb2015, Vol. 132 Issue 1, p9-20, 12p

Record details

Growth differentiation factor (GDF-15) concentration combined with Ca125 levels in serum is superior to commonly used cancer biomarkers in differentiation of pancreatic mass.

• Authors : Hogendorf, Piotr¹; Durczyński, Adam¹ .; Skulimowski, Aleksander¹

Subjects: *CA 125 test; *BLOOD serum analysis; *PANCREATIC cancerUNITED States

• Source: Cancer Biomarkers. 2018, Vol. 21 Issue 3, p505-511. 7p.

Record details

Supplementary table 3. List of significant expression profiles of XPA cells irradiated with 0.6J/m2 of UV (gray color) as compared to non-irradiated XPA controls.

• Source: Nature Cell Biology. May, 2009, Vol. 11 Issue 5.

Record details